Santa Cruz Biotechnology offers a broad range of HLA-A2 monoclonal antibodies for immunology and cell biology research. HLA-A2 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-A2 is a major histocompatibility complex (MHC) class I molecule that plays a critical role in the immune response by presenting peptide antigens to CD8+ T cells. HLA-A2 expression is essential for the recognition of infected or malignant cells, making it a key player in tumor immunology and transplantation biology. Understanding HLA-A2 function and regulation advances the development of targeted immunotherapies and improves transplant outcomes. Researchers can utilize HLA-A2 monoclonal antibodies to investigate antigen presentation mechanisms and immune system responses. The specificity of HLA-A2 monoclonal antibodies enables precise detection and characterization of MHC class I molecules in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for HLA-A2 support researchers worldwide in advancing our understanding of immune system function and disease mechanisms.